"Situé à Valenciennes (Hauts-de-France), le Centre de cancérologie Les Dentellières accueille ses patients dans des locaux modernes et parfaitement adaptés aux besoins des usagers et des professionnels de santé. Il comprend un service de radiothérapie avec un plateau technique innovant pour des traitements d’une extrême précision, une clinique de jour où sont administrés les traitements de chimiothérapie par une équipe d’infirmières formées spécifiquement, une pharmacie à usage intérieur et une unité de préparation des anti-cancéreux, un service de soins de support composé d'une équipe pluridisciplinaire et une unité de recherche clinique qui permet de faciliter l'accès des patients à l'innovation et aux avancées thérapeutiques."

During the past decade, Centre de cancérologie Les Dentellières conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de cancérologie Les Dentellières" #1 sponsor was "Centre Oscar Lambret" with 4 trials, followed by "Daiichi Sankyo, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de cancérologie Les Dentellières" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Aix Marseille Université" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Canceropôle Nord Ouest" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Centre de cancérologie Les Dentellières" are "Breast Cancer" (5 trials), "Aging" (1 trials), "Breast Cancer Stage II" (1 trials), "Breast Neoplasms" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Centre de cancérologie Les Dentellières" in a lesser frequency.

Most popular intervention types in "Centre de cancérologie Les Dentellières" are "Drug" (7 trials), "Behavioral" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Trastuzumab" (2 trials), "Ado-trastuzumab emtansine (T-DM1)" (1 trials), "Atezolizumab" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre de cancérologie Les Dentellières" are 9 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre de cancérologie Les Dentellières". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centre de cancérologie Les Dentellières, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre de cancérologie Les Dentellières, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".